Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

Q: What does CUSIP 046513107 represent in this 13F holders report?

CUSIP 046513107 is the security identifier for ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

121 institutional investors reported ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 046513107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 8,494,871
Total 13F shares: 77,585,671
Share change: +14,726,195
Total reported value: $1,130,387,589
Put/Call ratio: 61%
Price per share: $14.57
Number of holders: 121
Value change: +$244,721,751
Number of buys: 91
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 046513107:

Q4 2025 Q3 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	98%	8,308,900	$70,709,000	—	31 Mar 2020	13F
Redmile Group, LLC	13F	Company	62%	5,293,370	$45,047,000	—	31 Mar 2020	13F
MAVERICK CAPITAL LTD	13F	Company	61%	5,199,897	$44,251,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	54%	4,565,283	$38,851,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	45%	3,822,326	$32,527,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	41%	3,462,329	$29,463,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	34%	2,889,541	$24,590,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	34%	2,870,248	$24,427,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	29%	2,500,000	$21,275,000	—	31 Mar 2020	13F
BRIDGER MANAGEMENT, LLC	13F	Company	26%	2,246,401	$19,117,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	26%	2,245,710	$19,111,000	—	31 Mar 2020	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	21%	1,800,000	$15,318,000	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	20%	1,687,143	$14,357,000	—	31 Mar 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	18%	1,500,000	$12,765,000	—	31 Mar 2020	13F
Camber Capital Management LP	13F	Company	17%	1,478,753	$12,584,000	—	31 Mar 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	14%	1,220,241	$9,493,475	—	31 Mar 2020	13F
NORGES BANK	13F	Company	12%	1,003,746	$8,542,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	9.7%	827,730	$7,043,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	8.5%	719,382	$6,122,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	8.2%	693,990	$5,905,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	7.9%	673,185	$5,729,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	7.4%	632,645	$5,383,000	—	31 Mar 2020	13F
Alberta Investment Management Corp	13F	Company	6.3%	538,230	$4,580,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	5.1%	431,468	$3,672,000	—	31 Mar 2020	13F
PINNACLE ASSOCIATES LTD	13F	Company	5%	425,970	$3,625,000	—	31 Mar 2020	13F
Slate Path Capital LP	13F	Company	4.9%	420,000	$3,574,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	4.8%	405,544	$3,451,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	4.4%	372,407	$3,169,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	4.1%	351,670	$2,993,000	—	31 Mar 2020	13F
PACIFIC HEIGHTS ASSET MANAGEMENT LLC	13F	Company	3%	253,000	$2,839,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	3.8%	322,671	$2,745,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	3%	250,900	$2,135,000	—	31 Mar 2020	13F
Antipodean Advisors LLC	13F	Company	2.6%	221,000	$1,881,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	2.6%	217,691	$1,853,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	2.5%	215,138	$1,831,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	2.1%	180,459	$1,536,000	—	31 Mar 2020	13F
12 West Capital Management LP	13F	Company	1.9%	158,700	$1,351,000	—	31 Mar 2020	13F
WASATCH ADVISORS LP	13F	Company	1.6%	139,751	$1,189,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	1.3%	114,519	$975,000	—	31 Mar 2020	13F
Trellus Management Company, LLC	13F	Company	1.3%	110,000	$936,000	—	31 Mar 2020	13F
PDT Partners, LLC	13F	Company	1.3%	107,693	$916,000	—	31 Mar 2020	13F
AXA S.A.	13F	Company	1.1%	95,055	$809,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	1.1%	94,500	$804,000	—	31 Mar 2020	13F
Vident Investment Advisory, LLC	13F	Company	1.1%	91,557	$779,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	1.1%	91,000	$774,000	—	31 Mar 2020	13F
MACKAY SHIELDS LLC	13F	Company	0.99%	83,731	$713,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.95%	81,003	$689,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.95%	80,419	$683,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.92%	77,762	$662,000	—	31 Mar 2020	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.89%	75,966	$646,000	—	31 Mar 2020	13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) as of Q2 2020

As of 30 Jun 2020, Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,585,671 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Redmile Group, LLC, MAVERICK CAPITAL LTD, Consonance Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and Artal Group S.A.. This page lists 121 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

106

Q2 2020 holders

121

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.